Wealth Enhancement Advisory Services, LLC Exelixis, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $49 Billion
- Q1 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 110,036 shares of EXEL stock, worth $3.98 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
110,036
Previous 66,842
64.62%
Holding current value
$3.98 Million
Previous $2.23 Million
82.56%
% of portfolio
0.01%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding EXEL
# of Institutions
568Shares Held
252MCall Options Held
1.45MPut Options Held
1.13M-
Black Rock Inc. New York, NY33.5MShares$1.21 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.4MShares$1.07 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA23.4MShares$848 Million4.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.3MShares$554 Million0.8% of portfolio
-
State Street Corp Boston, MA11.4MShares$413 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $11.6B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...